Literature DB >> 16629447

[Serial MRI findings of intracranial tuberculomas: a case report and review of the literature].

Jun Tsugawa1, Hirosato Inoue, Yoshio Tsuboi, Kohich Takano, Hidetsuna Utsunomiya, Tatsuo Yamada.   

Abstract

Intracranial tuberculoma is an infectious disorder, occurring with or without tuberculous meningitis. Although intracranial tuberculoma is rare in developed countries, its frequency has increased in recent years in association with aging and immunocompromised hosts. Because of the low sensitivity of Mycobacterium tuberculosis cultures or of DNA detection from cerebrospinal fluid, diagnosis of intracranial tuberculoma is often difficult. Conventional magnetic resonance (MR) imaging of the tuberculoma yields variable results and is indistinct from other inflammatory lesions or brain tumors. We report the case of a 74-year-old woman with progressive neurologic deterioration. MR imaging of the brain showed multiple ring-like enhancing lesions in the supra- and infra-tentorial regions, mimicking multiple metastatic brain tumors. Diffusion-weighted imaging (DWI) of the brain showed homogeneous high signals in each lesion. A cavity in the lung suggested systemic involvement of tuberculosis. Despite extensive examination, tuberculosis could not be detected. Nevertheless, anti-tuberculosis treatment was administered. The patient's neurologic condition initially deteriorated for 4 weeks, then gradually improved. MRI showed marked improvement of the lesions after anti-tuberculosis treatment. Whereas conventional MRI is not specific in such cases, DWI might be useful for early assessment of intracranial tuberculosis.

Entities:  

Mesh:

Year:  2006        PMID: 16629447

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  1 in total

1.  Multiple intracranial tuberculomas mimicking granulocytic sarcomas in acute myeloid leukemia.

Authors:  Jae Sook Ahn; Duk Hwan Yang; Yoe Kyeoung Kim; Sang Hee Cho; In Young Kim; Je Jung Lee; Ik Joo Chung; Hyeoung Joon Kim
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.